| General Information of Drug Metabolite (DM) (ID: DM006846) |
| DM Name |
Met-4
|
| Structure |
|
|
3D MOL is unavailable
|
2D MOL is unavailable
|
|
|
|
|
|
|
|
| Full List of Drug-Metabolizing Enzyme (DME) Related to This DM |
| DME(s) Producing This DM through Metabolism |
| DME Name |
DME ID |
Reactant |
Reaction |
Related Drug |
REF |
|
Cytochrome P450 3A4 (CYP3A4)
|
DME0001
|
| Unclear - Unclear |
CYC-202
|
[1] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Full List of Drug(s) That Produce This DM By Metabolism |
| CYC-202 |
DR1858
|
Phase 2 |
Lung cancer |
|
|
| ATEVIRDINE |
DR3097
|
Phase 1 |
Human immunodeficiency virus infection |
|
|
| References |
| 1 |
Metabolism of the trisubstituted purine cyclin-dependent kinase inhibitor seliciclib (R-roscovitine) in vitro and in vivo. Drug Metab Dispos. 2008 Mar;36(3):561-70.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
